Skip to main content

Table 1 Testing capacity of health facilities for HBV-related investigations (2021)

From: A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021

 

Teaching

Regional

District

CHAG/QUASI

PHRL

NGO

Total n/N (%)

HBsAg

4/4

6/6

4/4

4/4

2/2

2/2

22/22 (100)

HBV Profile (RDT)

4/4

6/6

3/4

4/4

2/2

0/2

19/22 (86.4)

HBV Profile (ELISA)

3/4

2/6

0/4

0/4

1/2

 

6/20 (30.0)

HBV DNAa

4/4

0/6

0/4

1/4

1/2

 

6/20 (30.0)

Liver Function Test

4/4

6/6

3/4

4/4

  

17/18 (94.4)

INR

4/4

3/6

0/4

1/4

  

8/18 (44.4)

Abdominal Ultrasound

4/4

6/6

4/4

4/4

  

18/18 (100)

Abdominal CTb

4/4

2/6

0/4

2/4

  

8/18 (44.4)

Endoscopy

2/4

2/6

0/4

2/4

  

6/18 (33.3)

Biopsy

3/4

0/6

0/4

0/4

  

3/18 (16.7)

Genotyping

0/4

0/6

0/4

0/4

  

0/18 (0)

  1. NB: area shaded in grey represents tests that fall out of the purview of these institutions
  2. Abbreviations: RDT Rapid diagnostic test, ELISA Enzyme-linked immunosorbent assay, INR International normalised ratio
  3. aOnly two centres (teaching hospitals) had functional PCR machines at the time of assessment
  4. bOnly two centres (teaching hospitals) had functional CT scans at the time of assessment
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us